Tear biomarkers for Alzheimer’s disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study

BACKGROUND: Alzheimer’s disease (AD) is the most common cause of dementia, and due to increasing life expectancy the number of patients is expected to grow. The diagnosis of AD involves the use of biomarkers determined by an amyloid PET scan or cerebrospinal fluid analyses that are either invasive o...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Sande, Nienke, Ramakers, Inez H. G. B., Visser, Pieter Jelle, Verhey, Frans R. J., Verbraak, Frank D., Bouwman, Femke H., Berendschot, Tos T. J. M., Nuijts, Rudy M. M. A., Webers, Carroll A. B., Gijs, Marlies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403876/
https://www.ncbi.nlm.nih.gov/pubmed/37543602
http://dx.doi.org/10.1186/s12883-023-03335-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403876/
https://www.ncbi.nlm.nih.gov/pubmed/37543602
http://dx.doi.org/10.1186/s12883-023-03335-y

Ejemplares similares